Cymabay Therapeutics Inc (NASDAQ:CBAY)

2.10
Delayed Data
As of May 20
 +0.20 / +10.53%
Today’s Change
1.67
Today|||52-Week Range
5.06
-37.87%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Cymabay Therapeutics Inc have a median target of 10.00, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +376.19% increase from the last price of 2.10.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Cymabay Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.29
Sales
$0.00
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.59%
 
 
 
 
 
 
Growthannually 4.72%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.